Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

Summary

This study will investigate the ability of ST101 to improve memory in people with Alzheimer's disease who currently receive 10 mg Aricept® (donepezil) per day. This study also will examine the safety and tolerability of the drug. This study is evaluating 3 different dose levels of ST101 and placebo. Patients will have a 1 in 4 chance of getting placebo. All eligible subjects will be provided with bottles of 10 mg Aricept (donepezil) during the study drug administration part of the study.

Timeline

Start

2009-02

Primary completion

2011-05

Completion

2011-05

Drugs

Indications